Venture Valuation / Biotechgate

Venture Valuation provides product/asset as well as company valuations in the life sciences industry including biotechnology, medical technology, diagnostic, healthIT and pharma. The company’s valuations are used for fundraising/investment, M&A, fund valuations, licensing deals and fairness opinions. Furthermore, the company runs the business development database Biotechgate (www.biotechgate.com) as a subscription service. There are currently over 90’000 assets including 40’000 licensing opportunities, 700’000 clinical trials, 30’000 licensing agreements and over 60,000 company profiles available.

Venture Valuation specializes in independent assessments and valuations of companies and assets in the biopharma / life sciences industry. Valuations are provided for fundraising, investment decision, portfolio valuations, in- and out-licensing and M&A. The company also runs the global Biotech Database (www.biotechgate.com) as a subscription database service focused on early stage asset as well as a white label solution for clients like Ausbiotech, Advamed, Montreal Invivo, Bio.Maryland, BIO Deutschland, Medicon Valley. The most recent offering is Biotechgate Digital Partnering (www.digitalpartnering.com), virtual BD&L events organized by Venture Valuation. Biotechgate is part of Venture Valuation AG and is a global, comprehensive, life science database covering the Biotech, Pharma and Medtech industries. There are currently over 60,000 company profiles on the Biotechgate database.